What treatment
Inspiring Patient Success Stories
Explore Real Patient Experiences with
Trusted Medical Tourism Platform Since 2007
Fighting Relapsed DLBCL with Dual CAR-T Therapy
David, a 59-year-old teacher from Australia, traveled to Beijing, China, after standard chemotherapy failed to control his relapsed Diffuse Large B-Cell Lymphoma (DLBCL). He underwent Dual CD19 & CD20 CAR-T cell therapy, achieving rapid immune cell expansion and encouraging complete response indicators without major complications. Today, he continues his recovery with renewed hope and ongoing medical follow-up....
Read more detailsLeo Silva’s GD2 CAR-T Cell Therapy Journey for High-Risk Neuroblastoma
Leo, a 7-year-old from São Paulo, Brazil, was diagnosed with relapsed high-risk neuroblastoma after standard chemotherapy stopped working. His family traveled to Beijing, China, where he received GD2 CAR-T Cell Therapy at Bioocus Medical Group. Follow-up scans showed his tumors were shrinking, and he continues his recovery with renewed hope under ongoing medical supervision....
Read more detailsDavid Harrison's Refractory DLBCL Journey with CAR-T Therapy in China
David H., a 54-year-old civil engineer from Manchester, UK, traveled to Beijing, China, after his refractory Diffuse Large B-Cell Lymphoma (DLBCL) failed to respond to aggressive chemotherapy. He underwent Dual-Targeting CD19/CD20 CAR-T Therapy at Bioocus Medical Group, experiencing successful cell engraftment without severe complications. Today, he is recovering steadily, with improved energy levels and ongoing follow-up care....
Read more detailsDiscover your treatment options with a free, no-obligation quote!
Get your quote now!Discover your treatment options with a free, no-obligation quote!
Get your quote now!